Labcorp Holdings Additional Paid-in Capital 2012-2026 | LH
Labcorp Holdings additional paid-in capital from 2012 to 2026. Additional paid-in capital can be defined as the excess over par value paid for common securities.
- Labcorp Holdings additional paid-in capital for the quarter ending March 31, 2026 was $33M, a 0% increase year-over-year.
- Labcorp Holdings additional paid-in capital for 2024 was $0.003B, a 92.71% decline from 2023.
- Labcorp Holdings additional paid-in capital for 2023 was $0.038B, a 0% decline from 2022.
- Labcorp Holdings additional paid-in capital for 2022 was $0B, a 0% decline from 2021.
|
Labcorp Holdings Annual Additional Paid-in Capital (Millions of US $) |
|
|---|---|
| 2024 | $3 |
| 2023 | $38 |
| 2022 | |
| 2021 | $0 |
| 2020 | $110 |
| 2019 | $27 |
| 2018 | $1,451 |
| 2017 | $1,990 |
| 2016 | $2,132 |
| 2015 | $1,975 |
| 2014 | $0 |
| 2013 | |
| 2012 | |
| 2011 | |
|
Labcorp Holdings Quarterly Additional Paid-in Capital (Millions of US $) |
|
|---|---|
| 2025-09-30 | $33 |
| 2025-06-30 | $2 |
| 2025-03-31 | $36 |
| 2024-12-31 | $3 |
| 2024-09-30 | |
| 2024-06-30 | $13 |
| 2024-03-31 | $82 |
| 2023-12-31 | $38 |
| 2023-09-30 | $5 |
| 2023-06-30 | $94 |
| 2023-03-31 | $48 |
| 2022-12-31 | |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $29 |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | $67 |
| 2020-12-31 | $110 |
| 2020-09-30 | $81 |
| 2020-06-30 | $32 |
| 2020-03-31 | $0 |
| 2019-12-31 | $27 |
| 2019-09-30 | $48 |
| 2019-06-30 | $91 |
| 2019-03-31 | $1,401 |
| 2018-12-31 | $1,451 |
| 2018-09-30 | $1,828 |
| 2018-06-30 | $1,935 |
| 2018-03-31 | $1,969 |
| 2017-12-31 | $1,990 |
| 2017-09-30 | $1,998 |
| 2017-06-30 | $1,973 |
| 2017-03-31 | $2,051 |
| 2016-12-31 | $2,132 |
| 2016-09-30 | $2,130 |
| 2016-06-30 | $2,088 |
| 2016-03-31 | $2,023 |
| 2015-12-31 | $1,975 |
| 2015-09-30 | $1,938 |
| 2015-06-30 | $1,878 |
| 2015-03-31 | $1,823 |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | $0 |
| 2011-12-31 | |
| 2011-09-30 | $0 |
| 2011-06-30 | $73 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $20.863B | $13.952B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS Health (CVS) | United States | $129.251B | 14.33 |
| Danaher (DHR) | United States | $126.118B | 22.33 |
| Elevance Health (ELV) | United States | $85.740B | 12.83 |
| HCA Healthcare (HCA) | United States | $83.631B | 13.02 |
| Cencora (COR) | United States | $52.781B | 16.27 |
| Natera (NTRA) | United States | $32.768B | 0.00 |
| Viatris (VTRS) | United States | $17.911B | 6.28 |
| DiDi Global (DIDIY) | China | $16.365B | 25.64 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.375B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $13.258B | 54.19 |
| Medpace Holdings (MEDP) | United States | $13.014B | 28.64 |
| Solventum (SOLV) | United States | $12.739B | 11.79 |
| Revvity (RVTY) | United States | $11.049B | 19.34 |
| ICON (ICLR) | Ireland | $10.775B | 12.49 |
| BioMerieux (BMXMF) | France | $9.232B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.745B | 18.16 |
| HealthEquity (HQY) | United States | $7.074B | 23.57 |
| Sonic Healthcare (SKHHY) | Australia | $6.895B | 0.00 |
| Avantor (AVTR) | United States | $6.384B | 11.00 |
| PACS (PACS) | United States | $5.978B | 24.21 |
| GETINGE (GNGBY) | Sweden | $5.438B | 17.36 |
| Bausch + Lomb (BLCO) | Canada | $5.331B | 22.97 |
| CochLear (CHEOY) | Australia | $5.195B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $4.893B | 0.00 |
| Sotera Health (SHC) | United States | $4.489B | 19.92 |
| Alignment Healthcare (ALHC) | United States | $4.401B | 236.56 |
| Concentras Parent (CON) | United States | $3.646B | 19.78 |
| Organon (OGN) | United States | $3.519B | 4.27 |
| Establishment Labs Holdings (ESTA) | United States | $2.533B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 13.19 |
| Progyny (PGNY) | United States | $2.059B | 34.13 |
| Pediatrix Medical (MD) | United States | $1.932B | 11.59 |
| Surgery Partners (SGRY) | United States | $1.903B | 58.20 |
| Agilon Health (AGL) | United States | $1.887B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.732B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.704B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.645B | 65.20 |
| Teladoc Health (TDOC) | United States | $1.368B | 0.00 |
| Ardent Health (ARDT) | United States | $1.294B | 5.51 |
| CareDx (CDNA) | United States | $1.294B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.250B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| Omada Health (OMDA) | United States | $1.069B | 0.00 |
| Nutex Health (NUTX) | United States | $1.033B | 11.60 |
| GoodRx Holdings (GDRX) | United States | $0.880B | 16.06 |
| CryoPort (CYRX) | United States | $0.744B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Strata Critical Medical (SRTA) | United States | $0.498B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Oncology Institute (TOI) | United States | $0.495B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.389B | 4.74 |
| Shoulder Innovations (SI) | United States | $0.369B | 0.00 |
| Forward Industries (FWDI) | United States | $0.319B | 0.00 |
| SBC Medicals (SBC) | United States | $0.303B | 7.56 |
| LifeMD (LFMD) | United States | $0.208B | 0.00 |
| Embecta (EMBC) | United States | $0.180B | 1.17 |
| Biodesix (BDSX) | United States | $0.180B | 0.00 |
| So-Young (SY) | China | $0.159B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.100B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.087B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.086B | 14.28 |
| Park Dental Partners (PARK) | United States | $0.082B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| DocGo (DCGO) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.017B | 0.00 |
| Ainos (AIMD) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Pomdoctor - (POM) | China | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |